Bayer Reaches $2 Billion Deal Over Future Roundup Cancer Claims

Bayer Reaches $2 Billion Deal Over Future Roundup Cancer Claims
Monsanto Co's Roundup is shown for sale in Encinitas, California, June 26, 2017. Mike Blake/Reuters
Reuters
Updated:

Bayer AG struck a $2 billion deal to resolve future legal claims that its widely used weedkiller Roundup causes cancer, the German company said on Wednesday.

Bayer has been struggling to finalize the settlement of claims that Roundup and other glyphosate-based herbicides cause non-Hodgkin’s lymphoma, a type of cancer. Bayer inherited the business and the litigation as part of a $63 billion acquisition of Monsanto in 2018.